CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ 9,095	$ (118,018)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	19	25
Stock-based compensation expense	1,729	1,621
Loss on issuance of warrants	75,644
Change in fair value of convertible notes	1,631	87
Change in fair value of warrants	(86,729)	20,903
Change in fair value of embedded forward purchase agreements and derivative liabilities		22,917
Change in fair value of contingent consideration	(3,488)	63,769
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(298)	124
Accounts payable	(3,473)	3,136
Accrued expenses and other liabilities	(2,036)	(3,228)
Other assets and liabilities	(3)	64
Net cash used in operating activities	(7,909)	(8,600)
Cash flows from investing activities:
Purchases of property and equipment	(4)
Net cash used in investing activities	(4)
Cash flows from financing activities:
Proceeds from issuance of convertible notes		5,000
Proceeds from issuance of public offering shares, net	18,346
Net cash provided by financing activities	18,346	5,000
Net increase (decrease) in cash	10,433	(3,600)
Cash and cash equivalents at beginning of period	13	5,158
Cash and cash equivalents at end of period	10,446	$ 1,558
Non-cash financing activities:
Cashless warrant exercises	$ 6,418